Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
Clasificación en acciones #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Precio por acción
$0.0002
Última sincronización: 2026-08-12
Capitalización bursátil
$114.99K
Cambio (1 día)
0.00%
Cambio (1 año)
100.00%
País
US
Comercio Immunotech Laboratories, Inc. (IMMB)

Categoría

Historial del precio de la acción de Immunotech Laboratories, Inc. (IMMB)
Precio más alto de cierre: $0.00 el 2026-08-01

Precio más bajo de cierre: $0.00 el 2022-03-01
Historial del precio de la acción de Immunotech Laboratories, Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -40.00%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE